Brief: NovaBay Pharmaceuticals Reports 2020 Fourth Quarter And Full Year Financial Results

Stablecoin Development

25/03/2021 20:20

March 25 (Reuters) - NovaBay Pharmaceuticals Inc  NBY.A :
    * NOVABAY PHARMACEUTICALS REPORTS 2020 FOURTH QUARTER AND
FULL
YEAR FINANCIAL RESULTS
    * Q4 LOSS PER SHARE $0.04
    * NOVABAY PHARMACEUTICALS - NET PRODUCT REVENUE FOR Q4 OF
2020 WAS
$1.9 MILLION, A 10% INCREASE FROM $1.7 MILLION FOR Q4 OF 2019

Source text for Eikon:  ID:nBw9R9W08a 
Further company coverage:  NBY.A 

 ((Reuters.Briefs@thomsonreuters.com;))